{"id":915924,"date":"2025-12-03T16:09:15","date_gmt":"2025-12-03T21:09:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/"},"modified":"2025-12-03T16:09:15","modified_gmt":"2025-12-03T21:09:15","slug":"exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/","title":{"rendered":"Exelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025"},"content":{"rendered":"

<\/p>\n

Exelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025<\/b><\/p>\n

– Event to Review R&D Progress and Outline Exelixis\u2019 Strategy for Building Next-generation Oncology Franchises –<\/i><\/b><\/p>\n

ALAMEDA, Calif.–(BUSINESS WIRE<\/a>)–Exelixis, Inc.<\/a> (Nasdaq: EXEL) today announced that it will webcast its virtual event, Exelixis 2025 R&D Day: Building Next-generation Oncology Franchises, on Wednesday, December 10, 2025, from 1:00 p.m. to 3:30 p.m. EST. During the event, featured speakers will review the progress of Exelixis\u2019 R&D activities and outline the company\u2019s strategy to advance future oncology franchises. These efforts underscore Exelixis\u2019 continued focus on raising standards of care, helping more patients with cancer and generating long-term value for shareholders.\n<\/p>\n

\nThe live webcast and a recording of the event will be available at EXELRDDay.com<\/a>, as well as www.exelixis.com<\/a> on the Event Calendar page under the Investors & News heading, where the content will remain accessible for one year. To register and access the webcast, please use the registration code: EXELR&D. Participants are encouraged to register in advance to ensure timely access on the day of the event.\n<\/p>\n

About Exelixis<\/b><\/p>\n

\nExelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by drug discovery and development excellence, we are rapidly evolving our product portfolio to target an expanding range of tumor types and indications with our clinically differentiated pipeline of small molecules and biotherapeutics. This comprehensive approach harnesses decades of robust investment in our science and partnerships to advance our investigational programs and extend the impact of our flagship commercial product, CABOMETYX\u00ae<\/sup> (cabozantinib). Exelixis is driven by a bold scientific pursuit to create transformational treatments that give more patients hope for the future. For information about the company and its mission to help cancer patients recover stronger and live longer, visit www.exelixis.com<\/a>, follow @ExelixisInc<\/a> on X (Twitter), like Exelixis, Inc.<\/a> on Facebook and follow Exelixis<\/a> on LinkedIn.\n<\/p>\n

Exelixis, the Exelixis logo and CABOMETYX are registered U.S. trademarks.<\/i><\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20251203195955\/en\/<\/a><\/span><\/p>\n

Investors Contact:
\n<\/b>
Varant Shirvanian
\n<\/i>
Director, Investor Relations
\n<\/i>
Exelixis, Inc.
\n<\/i>
650-837-7917
\n<\/i>
vshirvanian@exelixis.com<\/i><\/a><\/p>\n

Media Contact:
\n<\/b>
Hal Mackins
\n<\/i>
For Exelixis, Inc.
\n<\/i>
415-994-0040
\n<\/i>
hal@torchcommunications.com<\/i><\/a><\/p>\n

KEYWORDS:<\/b> California United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Oncology Health General Health Research Science Pharmaceutical Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Exelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025 – Event to Review R&D Progress and Outline Exelixis\u2019 Strategy for Building Next-generation Oncology Franchises – ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that it will webcast its virtual event, Exelixis 2025 R&D Day: Building Next-generation Oncology Franchises, on Wednesday, December 10, 2025, from 1:00 p.m. to 3:30 p.m. EST. During the event, featured speakers will review the progress of Exelixis\u2019 R&D activities and outline the company\u2019s strategy to advance future oncology franchises. These efforts underscore Exelixis\u2019 continued focus on raising standards of care, helping more patients with cancer and generating long-term value for shareholders. The live webcast and a recording of the event will … <\/p>\n

Continue reading “Exelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-915924","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nExelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Exelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025 – Event to Review R&D Progress and Outline Exelixis\u2019 Strategy for Building Next-generation Oncology Franchises – ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that it will webcast its virtual event, Exelixis 2025 R&D Day: Building Next-generation Oncology Franchises, on Wednesday, December 10, 2025, from 1:00 p.m. to 3:30 p.m. EST. During the event, featured speakers will review the progress of Exelixis\u2019 R&D activities and outline the company\u2019s strategy to advance future oncology franchises. These efforts underscore Exelixis\u2019 continued focus on raising standards of care, helping more patients with cancer and generating long-term value for shareholders. The live webcast and a recording of the event will … Continue reading "Exelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-03T21:09:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251203195955r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Exelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025\",\"datePublished\":\"2025-12-03T21:09:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\\\/\"},\"wordCount\":410,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251203195955r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\\\/\",\"name\":\"Exelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251203195955r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-12-03T21:09:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251203195955r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251203195955r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/","og_locale":"en_US","og_type":"article","og_title":"Exelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025 - Market Newsdesk","og_description":"Exelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025 – Event to Review R&D Progress and Outline Exelixis\u2019 Strategy for Building Next-generation Oncology Franchises – ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that it will webcast its virtual event, Exelixis 2025 R&D Day: Building Next-generation Oncology Franchises, on Wednesday, December 10, 2025, from 1:00 p.m. to 3:30 p.m. EST. During the event, featured speakers will review the progress of Exelixis\u2019 R&D activities and outline the company\u2019s strategy to advance future oncology franchises. These efforts underscore Exelixis\u2019 continued focus on raising standards of care, helping more patients with cancer and generating long-term value for shareholders. The live webcast and a recording of the event will … Continue reading \"Exelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-03T21:09:15+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251203195955r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Exelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025","datePublished":"2025-12-03T21:09:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/"},"wordCount":410,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251203195955r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/","name":"Exelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251203195955r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-12-03T21:09:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251203195955r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251203195955r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exelixis-to-webcast-virtual-2025-research-development-rdday-on-wednesday-december-10-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Exelixis to Webcast Virtual 2025 Research & Development (R&D)Day on Wednesday, December 10, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/915924","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=915924"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/915924\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=915924"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=915924"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=915924"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}